Detection_NN
of_IN
minimal_JJ
residual_JJ
disease_NN
in_IN
a_DT
patient_NN
with_IN
acute_JJ
promyelocytic_JJ
leukemia_NN
by_IN
RT-PCR_NN
:_:
necessity_NN
of_IN
chemotherapy_NN
following_VBG
ATRA_NN
therapy_NN
._.

The_DT
PML\/RAR_NN
alpha_NN
fusion_NN
gene_NN
resulting_VBG
from_IN
the_DT
t_NN
-LRB-_-LRB-
15_CD
;_:
17_CD
-RRB-_-RRB-
translocation_NN
is_VBZ
a_DT
specific_JJ
marker_NN
for_IN
acute_JJ
promyelocytic_JJ
leukemia_NN
-LRB-_-LRB-
APL_NN
-RRB-_-RRB-
._.

We_PRP
examined_VBD
bone_NN
marrow_NN
cells_NNS
by_IN
reverse_JJ
transcriptase-polymerase_NN
chain_NN
reaction_NN
-LRB-_-LRB-
RT-PCR_NN
-RRB-_-RRB-
to_TO
detect_VB
residual_JJ
PML\/RAR_NN
alpha_NN
mRNA-containing_JJ
cells_NNS
following_VBG
treatment_NN
with_IN
all-trans_JJ
retinoic_JJ
acid_NN
-LRB-_-LRB-
ATRA_NN
-RRB-_-RRB-
and_CC
cytotoxic_JJ
chemotherapy_NN
in_IN
a_DT
patient_NN
with_IN
APL_NN
._.

This_DT
RT-PCR_NN
assay_NN
can_MD
detect_VB
one_CD
leukemic_JJ
cell_NN
in_IN
10_CD
2_CD
normal_JJ
cells_NNS
in_FW
vitro_FW
._.

We_PRP
show_VBP
that_IN
PML\/RAR_NN
alpha_NN
mRNA_NN
was_VBD
still_RB
detectable_JJ
despite_IN
clinical_JJ
remission_NN
following_VBG
ATRA_NN
treatment_NN
,_,
but_CC
undetectable_JJ
following_VBG
consolidation_NN
with_IN
chemotherapy_NN
._.

These_DT
data_NNS
show_VBP
that_IN
this_DT
technique_NN
is_VBZ
useful_JJ
for_IN
the_DT
identification_NN
of_IN
minimal_JJ
residual_JJ
disease_NN
in_IN
patients_NNS
with_IN
APL_NN
and_CC
that_IN
cytotoxic_JJ
chemotherapy_NN
following_VBG
ATRA_NN
therapy_NN
is_VBZ
required_VBN
for_IN
the_DT
elimination_NN
of_IN
APL_NN
cells_NNS
._.

